Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors

OBJECTIVE: To define the characteristics and the outcome of myelitis associated with immune checkpoint inhibitors (ICIs). METHODS: We performed a retrospective research in the databases of the French Pharmacovigilance Agency and the OncoNeuroTox network for patients who developed myelitis following...

Descripción completa

Detalles Bibliográficos
Autores principales: Picca, Alberto, Berzero, Giulia, Bihan, Kevin, Jachiet, Vincent, Januel, Edouard, Coustans, Marc, Cauquil, Cecile, Perrin, Julie, Berlanga, Pablo, Kramkimel, Nora, Garel, Bethsabée, Devic, Perrine, Ducray, François, Benazra, Marion, Bompaire, Flavie, Leclercq, Delphine, Michot, Jean-Marie, Ammari, Samy, Psimaras, Dimitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954463/
https://www.ncbi.nlm.nih.gov/pubmed/33637598
http://dx.doi.org/10.1212/NXI.0000000000000967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954463/
https://www.ncbi.nlm.nih.gov/pubmed/33637598
http://dx.doi.org/10.1212/NXI.0000000000000967

Ejemplares similares